GO:0015850 organic hydroxy compound transport: Transport Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015850 organic hydroxy compound transport describes the directed movement of organic alcohol molecules into, out of, or within cells via transporters or pores.
• This process is essential for nutrient uptake, drug pharmacokinetics, and detoxification across organisms.
• Key transporter families include solute carriers (SLCs), ATP-binding cassette (ABC) transporters, and aquaporins that facilitate hydroxy compound flux.
• Dysregulation of organic hydroxy compound transport is linked to metabolic disorders, cancer, and neurological diseases.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of transporter function in disease.
• Advanced methods such as Ribo-seq, RNA-seq, and proteomics reveal transport regulation at systems level.
Description
Organic hydroxy compound transport (GO:0015850) is a fundamental biological process that governs the directed movement of organic alcohol molecules across cellular membranes and within cellular compartments. This process is mediated by specialized transporter proteins and pores that ensure the proper distribution of hydroxy compounds, which include essential metabolites, signaling molecules, and xenobiotics. Understanding this transport mechanism is critical for researchers studying cellular metabolism, drug disposition, and disease pathogenesis. The transport of organic hydroxy compounds is not merely a passive diffusion phenomenon; it requires specific molecular machinery that recognizes and translocates these polar molecules across lipid bilayers. Recent advances in analytical techniques have enabled precise quantification of hydroxy compound transport in complex biological matrices, revealing its importance in both physiological and pathological contexts. In agricultural and environmental settings, the transport of hydroxy compounds such as hydroxy-chlorothalonil affects soil contamination and crop safety. Similarly, in mammals, the pharmacokinetics of compounds like ochratoxin A depend on efficient hydroxy compound transport systems. These diverse examples underscore the broad relevance of GO:0015850 across biomedical, agricultural, and environmental research.
organic hydroxy compound transport At A Glance
| GO ID | GO:0015850 |
|---|---|
| GO term | organic hydroxy compound transport |
| Ontology | biological_process |
| Synonym | organic alcohol transport |
| Major function | Directed movement of organic hydroxy compounds across membranes via transporters or pores |
| Definition source | QuickGO |
| Related cellular component | Plasma membrane, organelle membranes, transporter complexes |
| Related molecular function | Transporter activity, channel activity, ATPase-coupled transport |
| Taxonomic range | All domains of life including bacteria, plants, fungi, and animals |
What Is GO:0015850?
According to the Gene Ontology, GO:0015850 organic hydroxy compound transport is defined as the directed movement of an organic hydroxy compound (also known as an organic alcohol) into, out of, or within a cell, or between cells, by means of some agent such as a transporter or pore. An organic hydroxy compound is any organic compound that possesses at least one hydroxy group attached to a carbon atom. This definition encompasses the translocation of a wide range of molecules, from simple alcohols like ethanol to complex polyols and phenolic compounds, across biological membranes. The process requires specific transport proteins, including channels, carriers, and pumps, that facilitate the movement of these hydrophilic molecules through hydrophobic membrane barriers.
Why Is organic hydroxy compound transport Important in Cell Biology?
Organic hydroxy compound transport is critically important because it controls the cellular and systemic distribution of numerous bioactive molecules, including nutrients, hormones, drugs, and toxins. Dysregulation of this process can lead to metabolic imbalances, altered drug efficacy, and disease progression. For example, impaired transport of hydroxy compounds in the kidney or liver can cause toxic accumulation or deficient delivery to target tissues. In plants, the transport of hydroxy compounds like N-hydroxy pipecolic acid methyl ester is essential for immunity and defense signaling. In environmental contexts, the transport of hydroxy-chlorothalonil in soils influences its persistence and bioavailability, impacting ecosystem health. Therefore, studying GO:0015850 provides insights into fundamental biology and offers translational opportunities for pharmacology, toxicology, and agriculture.
• Regulates nutrient and metabolite distribution across cellular compartments.
• Determines pharmacokinetics and toxicity of drugs and xenobiotics.
• Plays a key role in plant immunity via transport of defense-related hydroxy compounds.
• Influences soil contamination and remediation through transport of hydroxy pesticides.
• Linked to metabolic disorders such as pseudoaldosteronism caused by licorice compounds.
• Affects cancer biology by modulating availability of signaling alcohols.
• Essential for neurological function by transporting neurotransmitters and their precursors.
• Target for prodrug design to improve cellular uptake of antiviral nucleosides.
• Contributes to biomarker discovery for polycyclic aromatic hydrocarbon exposure.
• Provides a basis for CRISPR-based functional genomics of transporter genes.
What Happens During organic hydroxy compound transport?
Substrate recognition and binding
In simple terms: The transporter first grabs the hydroxy compound.
Transport begins when a membrane-embedded transporter protein recognizes and binds its specific organic hydroxy compound substrate. This recognition is often mediated by hydrogen bonding and hydrophobic interactions within the transporter's binding pocket. For example, solute carrier (SLC) transporters exhibit selectivity for particular hydroxy compounds based on their size, charge, and stereochemistry. In plants, the transport of N-hydroxy pipecolic acid methyl ester requires specific carrier proteins that recognize this immune signal. The binding step is critical for ensuring that only appropriate molecules are translocated, preventing wasteful or harmful transport.
Conformational change and translocation
In simple terms: The transporter changes shape to move the molecule across the membrane.
Upon substrate binding, the transporter undergoes a conformational change that moves the hydroxy compound from one side of the membrane to the other. This can occur via alternating access mechanisms, where the binding site alternates between outward-facing and inward-facing states. ATP-binding cassette (ABC) transporters utilize ATP hydrolysis to drive this conformational cycle, while channels and facilitative carriers rely on concentration gradients. The translocation step is highly regulated and can be influenced by membrane potential, pH, and post-translational modifications. In soil environments, the transport of hydroxy-chlorothalonil is affected by sorption-desorption processes that mimic biological transport mechanisms.
Release and cellular distribution
In simple terms: The molecule is released inside the cell or compartment.
After translocation, the hydroxy compound is released from the transporter into the cytoplasm or target organelle. This release may be facilitated by changes in binding affinity or by interaction with intracellular binding proteins. Once inside, the compound can be further metabolized, stored, or exported by other transporters. In mammals, the release of hydroxy compounds such as ochratoxin A into cells can lead to toxicity if not properly detoxified. In plants, the release of N-hydroxy pipecolic acid methyl ester triggers downstream immune responses. The efficiency of release influences the overall transport rate and cellular homeostasis.
Regulation and feedback control
In simple terms: The cell adjusts transport based on need.
Organic hydroxy compound transport is dynamically regulated at multiple levels, including transporter gene expression, protein trafficking, and post-translational modifications. For instance, the activity of SLC transporters can be modulated by phosphorylation or ubiquitination in response to cellular stress. In plants, the transport of defense-related hydroxy compounds is upregulated upon pathogen attack. In humans, the transport of licorice-derived glycyrrhetinic acid is influenced by diet and genetic polymorphisms, leading to variable susceptibility to pseudoaldosteronism. Feedback mechanisms ensure that transport rates match physiological demands and prevent toxic accumulation.
Integration with metabolism and signaling
In simple terms: Transport is linked to the cell's metabolic and signaling networks.
Transport of organic hydroxy compounds is tightly integrated with cellular metabolism and signaling pathways. For example, the transport of polyols like sorbitol is coupled to osmotic stress responses. In cancer cells, altered transport of hydroxy compounds can support rapid growth by supplying precursors for biosynthesis. In the brain, transporters for hydroxy metabolites of neurotransmitters regulate synaptic transmission. Environmental factors such as surfactants can modify the transport of hydroxy compounds in soil, affecting their bioavailability and degradation. Thus, GO:0015850 is a nexus for metabolic, signaling, and environmental interactions.
Key Genes Involved in GO:0015850 organic hydroxy compound transport
The following genes and proteins are representative transporters and regulators involved in organic hydroxy compound transport across various organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC2A1 (GLUT1) | Facilitates glucose and polyol transport | Cancer metabolism, blood-brain barrier |
| SLC5A1 (SGLT1) | Sodium-coupled glucose and hydroxy compound transport | Diabetes, intestinal absorption |
| ABCB1 (P-glycoprotein) | ATP-dependent efflux of hydroxy compounds | Multidrug resistance, pharmacokinetics |
| ABCG2 (BCRP) | Efflux transporter for hydroxy drugs | Cancer chemoresistance, drug disposition |
| AQP1 | Water and small hydroxy compound channel | Kidney function, cell migration |
| AQP3 | Glycerol and hydroxy compound transport | Skin hydration, cancer |
| SLC22A1 (OCT1) | Organic cation and hydroxy compound uptake | Drug response, liver function |
| SLC22A6 (OAT1) | Organic anion and hydroxy compound transport | Renal secretion, toxicity |
| SLC16A1 (MCT1) | Monocarboxylate and hydroxy compound transport | Metabolic reprogramming, cancer |
| SLC16A3 (MCT4) | Lactate and hydroxy compound efflux | Tumor microenvironment |
| SLC7A11 | Cystine/glutamate antiporter, affects hydroxy compound balance | Ferroptosis, cancer |
| SLC3A2 | Chaperone for SLC7A11, hydroxy compound transport | Amino acid transport, immunity |
| SLC15A1 (PEPT1) | Dipeptide and hydroxy compound transport | Prodrug absorption |
| SLC28A1 (CNT1) | Nucleoside and hydroxy compound transport | Antiviral therapy |
| SLC29A1 (ENT1) | Equilibrative nucleoside and hydroxy compound transport | Cardiovascular disease, cancer |
| SLC6A4 (SERT) | Serotonin (hydroxy compound) transport | Depression, anxiety |
| SLC18A2 (VMAT2) | Vesicular monoamine (hydroxy compound) transport | Neurodegeneration |
How Is organic hydroxy compound transport Regulated?
Organic hydroxy compound transport is regulated at transcriptional, post-transcriptional, and post-translational levels. Transcription factors such as HIF-1α and Nrf2 modulate the expression of SLC and ABC transporters in response to hypoxia and oxidative stress. Post-translational modifications, including phosphorylation and ubiquitination, control transporter trafficking and activity. In plants, the transport of N-hydroxy pipecolic acid methyl ester is regulated by immune signaling pathways involving salicylic acid. In soil, the transport of hydroxy-chlorothalonil is influenced by surfactant amendments that alter sorption and degradation. Hormonal signals, such as insulin and glucocorticoids, also regulate glucose and polyol transporters in metabolic tissues. These regulatory layers ensure that organic hydroxy compound transport adapts to changing physiological and environmental conditions.
organic hydroxy compound transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC2A1 | GLUT1 deficiency syndrome, cancer metabolism | Knockout in HEK293, patient iPSC-derived neurons |
| ABCB1 | Multidrug resistance in cancer | Knockout in K562, overexpression in MCF-7 |
| SLC6A4 | Depression, anxiety | Knockout in mice, point mutation in serotonergic neurons |
| SLC22A6 | Renal toxicity, drug disposition | Knockout in renal proximal tubule cells |
| SLC18A2 | Parkinson's disease | Knock-in of disease variants in dopaminergic neurons |
Metabolic and endocrine disorders
Dysregulated transport of organic hydroxy compounds contributes to metabolic diseases such as diabetes and obesity. For example, altered expression of SLC2A1 (GLUT1) and SLC5A1 (SGLT1) affects glucose homeostasis and is targeted in diabetes therapy. Licorice-induced pseudoaldosteronism results from impaired transport and metabolism of glycyrrhetinic acid, a hydroxy compound that inhibits 11β-hydroxysteroid dehydrogenase. These examples highlight how transport defects can lead to endocrine imbalances and metabolic syndrome.
Cancer and chemoresistance
Cancer cells often reprogram organic hydroxy compound transport to support rapid proliferation and survival. Overexpression of ABCB1 and ABCG2 efflux transporters reduces intracellular accumulation of chemotherapeutic hydroxy compounds, leading to multidrug resistance. Conversely, increased uptake of hydroxy metabolites via SLC transporters can fuel biosynthetic pathways. Targeting these transporters with CRISPR knockout or inhibitors is a promising strategy to overcome resistance.
Neurological and psychiatric disorders
In the nervous system, transporters for hydroxy compounds such as serotonin and dopamine regulate synaptic transmission. SLC6A4 (SERT) is the target of antidepressants, and its dysfunction is linked to depression and anxiety. SLC18A2 (VMAT2) transports monoamines into synaptic vesicles, and its impairment is associated with Parkinson's disease. Thus, organic hydroxy compound transport is central to neuropharmacology and neurodegeneration.
Environmental and agricultural health
Transport of hydroxy compounds in soil affects the fate of pesticides and pollutants. Hydroxy-chlorothalonil, a degradation product of the fungicide chlorothalonil, is transported through soil and can contaminate water sources. Understanding its transport mechanisms aids in risk assessment and remediation. In plants, transport of N-hydroxy pipecolic acid methyl ester is crucial for immunity, and manipulating this pathway could enhance crop resistance.
From organic hydroxy compound transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SLC2A1 affect glucose transport? | CRISPR knockout in HEK293 cells |
| Does a point mutation in SLC6A4 alter serotonin uptake? | Point mutation knock-in in iPSC-derived neurons |
| Can overexpression of ABCB1 confer chemoresistance? | Overexpression in cancer cell lines |
| Does tagging SLC22A6 reveal its localization? | Tagged knock-in in renal cells |
| Does knockout of AQP3 impair glycerol transport? | Knockout in keratinocytes |
| Can CRISPR library screening identify novel hydroxy compound transporters? | Genome-wide knockout library in HeLa cells |
How to Study the organic hydroxy compound transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled uptake assay | Transport rate of hydroxy compounds | Characterizing SLC transporter kinetics |
| LC-MS | Quantification of specific hydroxy compounds | Plant immunity, soil transport |
| RNA-seq | Transporter gene expression | Cancer metabolism, drug response |
| Ribo-seq | Translational efficiency of transporters | Stress response, immune signaling |
| Proteomics | Protein abundance and modifications | Transporter regulation |
| Fluorescence microscopy | Subcellular localization | Trafficking studies |
| CRISPR screen | Genes affecting transport | Drug resistance, toxicity |
| Bioinformatics | Pathway enrichment, network analysis | Systems-level understanding |
Transport assays
Radiolabeled or fluorescently labeled hydroxy compounds are used to measure uptake or efflux in cells expressing candidate transporters. These assays can be performed in real-time using chemical calcium indicators to monitor intracellular signaling. For example, the transport of N-hydroxy pipecolic acid methyl ester in plant cells can be quantified using LC-MS.
Transcriptomics and proteomics
RNA-seq and Ribo-seq reveal expression changes of transporter genes under different conditions. Proteomics can identify interacting partners and post-translational modifications of transporters. In environmental samples, metagenomics and metatranscriptomics uncover microbial transport pathways for hydroxy compounds.
Imaging and localization
Fluorescence microscopy with tagged transporters (e.g., GFP) visualizes subcellular localization and trafficking. Live-cell imaging using chemical indicators can track hydroxy compound flux in real time. In plants, confocal imaging of fluorescently labeled N-hydroxy pipecolic acid methyl ester reveals its distribution during immunity.
Genetic screens and CRISPR
Genome-wide CRISPR knockout or activation screens identify genes that regulate organic hydroxy compound transport. These screens can be coupled with selection using toxic hydroxy compounds or fluorescent substrates. Bioinformatics analysis of screen hits reveals enriched pathways and potential drug targets.
How CRISPR Can Be Used to Study GO:0015850 organic hydroxy compound transport
Knockout
CRISPR knockout of transporter genes such as SLC2A1 or ABCB1 abolishes transport activity, allowing researchers to measure the functional consequences on cellular metabolism, drug sensitivity, and signaling. For example, knockout of SLC22A6 in renal cells impairs organic anion transport and increases toxicity of hydroxy compounds. In plants, knockout of N-hydroxy pipecolic acid methyl ester transporters reduces immunity.
Point Mutation
Point mutations introduced by CRISPR base editing or HDR can mimic disease-associated variants in transporter genes. For instance, a point mutation in SLC6A4 that alters serotonin transport can be modeled in iPSC-derived neurons to study depression. Similarly, mutations in SLC2A1 cause GLUT1 deficiency syndrome, and point-mutation models help dissect transport kinetics.
Knock-in
Knock-in of tagged transporters (e.g., GFP or HA) enables visualization and immunoprecipitation of endogenous proteins. Knock-in of disease variants, such as those in SLC18A2 linked to Parkinson's disease, provides physiologically relevant models. In soil microbiology, knock-in of fluorescent reporters into hydroxy compound transporters tracks their expression in situ.
Overexpression
Overexpression of transporters like ABCG2 or SLC16A3 in cancer cell lines increases efflux or uptake of hydroxy compounds, conferring chemoresistance or metabolic advantages. Overexpression in plants can enhance transport of defense compounds and improve immunity. These models are valuable for drug screening and resistance studies.
How EDITGENE Supports organic hydroxy compound transport Research
Researchers studying organic hydroxy compound transport-related genes often need to determine whether a candidate gene is causally involved in transport, how mutations affect function, and whether modulating its activity can alter disease phenotypes. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and scale.
Contact EDITGENE today to design your custom CRISPR model for organic hydroxy compound transport research.
Frequently Asked Questions About organic hydroxy compound transport
What is GO:0015850 organic hydroxy compound transport?
GO:0015850 is a Gene Ontology biological process term describing the directed movement of organic hydroxy compounds (organic alcohols) into, out of, or within cells via transporters or pores.
What genes are involved in organic hydroxy compound transport?
Key genes include SLC2A1, SLC5A1, ABCB1, ABCG2, AQP1, AQP3, SLC22A1, SLC22A6, SLC16A1, SLC6A4, and SLC18A2, among others.
Why is organic hydroxy compound transport important?
It controls nutrient uptake, drug pharmacokinetics, detoxification, and signaling, and its dysregulation is linked to metabolic, neurological, and neoplastic diseases.
How is organic hydroxy compound transport regulated?
It is regulated at transcriptional, post-transcriptional, and post-translational levels by factors such as HIF-1α, Nrf2, phosphorylation, and ubiquitination.
What diseases are associated with defects in organic hydroxy compound transport?
Diseases include GLUT1 deficiency syndrome, multidrug-resistant cancer, depression, Parkinson's disease, and licorice-induced pseudoaldosteronism.
What methods are used to study organic hydroxy compound transport?
Common methods include radiolabeled uptake assays, LC-MS, RNA-seq, Ribo-seq, proteomics, fluorescence microscopy, and CRISPR screens.
Can CRISPR be used to study organic hydroxy compound transport?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of transporter function in disease and drug response.
What is the role of SLC transporters in organic hydroxy compound transport?
SLC transporters mediate the uptake of various hydroxy compounds, including glucose, nucleosides, and neurotransmitters, across cell membranes.
How does organic hydroxy compound transport affect drug resistance?
Efflux transporters such as ABCB1 and ABCG2 pump hydroxy drugs out of cells, reducing intracellular drug concentrations and causing chemoresistance.
What is the connection between organic hydroxy compound transport and plant immunity?
Transport of N-hydroxy pipecolic acid methyl ester is essential for systemic acquired resistance in Arabidopsis, highlighting the role of hydroxy compound transport in plant defense.
Conclusion
GO:0015850 organic hydroxy compound transport is a fundamental biological process with broad implications for human health, pharmacology, agriculture, and environmental science. Understanding its molecular mechanisms and regulation provides insights into disease pathogenesis and offers targets for therapeutic intervention. CRISPR-based models and advanced omics technologies are invaluable tools for dissecting this process and translating findings into clinical and agricultural applications.
References
- 1. Paredes RM et al.. 2008. Chemical calcium indicators.. Methods 46(3):143-51 PMID: 18929663
- 2. Chen Y et al.. 2023. Retardation factors in controlling the transport of inorganic, organic, and particulate phosphorus in fluvo-aquic soil.. Ecotoxicol Environ Saf 249:114402 PMID: 36516624
- 3. Makino T. 2021. Exploration for the real causative agents of licorice-induced pseudoaldosteronism.. J Nat Med 75(2):275-283 PMID: 33481180
- 4. Galtier P. 1991. Pharmacokinetics of ochratoxin A in animals.. IARC Sci Publ PMID: 1820333
- 5. Mohnike L et al.. 2023. N-Hydroxy pipecolic acid methyl ester is involved in Arabidopsis immunity.. J Exp Bot 74(1):458-471 PMID: 36260503
- 6. Styszko K et al.. 2023. Biomarkers for polycyclic aromatic hydrocarbons in human excreta: recent advances in analytical techniques-a review.. Environ Geochem Health 45(10):7099-7113 PMID: 37530922
- 7. Krecmerova M. 2017. Amino Acid Ester Prodrugs of Nucleoside and Nucleotide Antivirals.. Mini Rev Med Chem 17(10):818-833 PMID: 28215138
- 8. Báez ME et al.. 2023. Effect of surfactants on the sorption-desorption, degradation, and transport of chlorothalonil and hydroxy-chlorothalonil in agricultural soils.. Environ Pollut 327:121545 PMID: 37004862
